In 2023, Germany dominated the European market for the production of medicaments containing vitamins, provitamins, derivatives, and intermixtures, with a value of 3.8471 billion euros. Italy showed significant improvement with a year-on-year increase of 14.63%, indicating potential growth. Spain (12.25%) and Austria (9.8%) also exhibited strong growth trends. Conversely, Denmark saw a substantial decline of 26.97%, and France experienced a decrease of 6.8%, suggesting market challenges in these areas.
For future trends, watch for:
- Continued growth potential in Italy and Spain due to increased production capacities.
- The potential for recovery in France and Denmark if strategic adjustments are implemented.
- The impact of regulatory changes and market demand on overall production in Europe.
Top countries in Sold Production of Medicaments Containing Vitamins, Provitamins, Derivatives and Intermixtures Thereof by Country
| # | 10 Countries | Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 3,847,100,000 | 2023 | +3.19% | +1.74% | View data |
| 2 | 2 Italy | 498,790,000 | 2023 | +10.21% | +14.63% | View data |
| 3 | 3 United Kingdom | 374,950,000 | 2023 | +1.87% | +2.41% | View data |
| 4 | 4 Spain | 319,370,000 | 2023 | +11.18% | +12.25% | View data |
| 5 | 5 Ireland | 262,330,000 | 2021 | +20.79% | View data | |
| 6 | 6 Austria | 181,770,000 | 2023 | +5.68% | +9.8% | View data |
| 7 | 7 France | 107,450,000 | 2023 | -8.87% | -6.8% | View data |
| 8 | 8 Hungary | 89,586,000 | 2023 | +3.49% | +4.29% | View data |
| 9 | 9 Greece | 58,454,000 | 2023 | +2.28% | +3.06% | View data |
| 10 | 10 Poland | 56,936,000 | 2023 | +0.58% | -0.85% | View data |
